S
epsis is the development of a systemic inflammatory response in the presence of infection. The response is characterized by several circulatory disorders, including impaired red blood cell flow in the microcirculation (1, 2) . Despite fluid resuscitation, adequate arterial blood oxygenation and cardiac output in septic patients, this impairment is evidenced by the decreased density of perfused capillaries and increased proportion of nonperfused capillaries (3) . The impairment leads to tissue hypoxia because the diffusion distance for oxygen increases (4) . Tissue hypoxia may explain why microvascular dysfunction is a strong predictor of death and why one third of severe sepsis patients die of organ failure even when shock is prevented (3, 5) . Several studies have examined septic impairment of capillary blood flow without identifying definitively the principal underlying mechanism (2, 6 -9) .
Increased production of nitric oxide (NO) by nitric oxide synthase (NOS) has been implicated in sepsis-induced impairment of microvascular responsiveness (10 -13) and capillary blood flow (9) . However, pharmacologic studies of the roles of NOS isoforms have been confounded by the relative lack of specificity of the NOS inhibitors employed (14) . Inducible NOS (iNOS) protein expression is up-regulated transiently during early stages of sepsis (15, 16) while, at later stages, neuronal NOS (nNOS) or its splice variants may be responsible for impaired microvascular responsiveness (10, 14, 17) .
Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase is the major source of superoxide in microvascular endothelial cells (18, 19) . However, the effect of NADPH oxidase on capillary blood flow in sepsis is unknown. Antioxidants such as ascorbate improve outcome of clinical (20 -22) and experimental sepsis (23) (24) (25) (26) . Ascorbate scavenges reactive oxygen species (ROS), inhibits protein expression of NADPH oxidase enzymes that are potential sources of ROS, and increases levels of NO derived from endothelial NOS (eNOS) (11, 19, 27) .
Based on these facts, major objectives of the present study were to determine the roles of NOS and NADPH oxidase in the impairment of capillary blood flow in sepsis, and in the rapid reversal of this impairment by ascorbate. We used genetically modified mice with either isoformspecific NOS gene deletions or NADPH oxidase subunit gp91phox deletion.
METHODS
Animal Preparation. The experimental protocol was approved by the University of Western Ontario Council on Animal Care. Male wild type (WT), nNOS Ϫ/Ϫ , iNOS Ϫ/Ϫ , eNOS Ϫ/Ϫ , and gp91phox Ϫ/Ϫ mice of C57BL/6 background (weight: 18 -25 g, age: 1.5-4 months) were obtained from Jackson Laboratory (Bar Harbor, ME). Sepsis was induced by feces injection into peritoneum (FIP) (28) . Feces were collected from the cecum of a donor mouse, mixed with sterile saline at concentration 75 mg/mL, and then stored overnight at 4°C. The next day, the mixture was rewarmed to room temperature for 10 mins, and an aliquot (50 mL/kg) was injected intraperitoneally. Next, sterile saline (1 mL) containing the analgesic buprenorphine (4 g/mL) was injected subcutaneously, beginning immediately after FIP and then at 6-hr intervals. Control mice were injected intraperitoneally with sterile saline (50 mL/kg), and also subcutaneously with 1 mL of saline and buprenorphine, beginning immediately after the intraperitoneal injection and then at 6-hr intervals.
At 5.5 or 17.5 hrs post-FIP, mice were anesthetized with ketamine (80 mg/kg) plus xylazine (4 mg/kg) and kept anesthetized with supplemental doses as required, for up to 2 hrs. For intravital video microscopy, as we have described in detail (26) , the surface of the right extensor digitorum longus (EDL) muscle was surgically exposed, covered by a glass coverslip, allowed a 30-min stabilization period, and then observed to: 1) visualize capillaries within a 0.61 ϫ 0.87 mm video-recorded field of view (ϳ0.1 mm depth of field) at the muscle surface; 2) measure the number of capillaries with moving and stationary red blood cells crossing a test line drawn on the video monitor; and 3) convert these counts to the densities of perfused and nonperfused capillaries per mm of test line, CD PER and CD STAT , respectively. We recorded capillaries in five randomly chosen fields in each muscle and then computed the average CD PER and CD STAT values per muscle. In several experiments, we also used the video flying spot technique (10) to measure the red blood cell velocity (V RBC ) in randomly selected perfused capillaries at the EDL muscle surface. In a subset of mice, the right internal carotid artery was exposed to withdraw a 0.3 mL blood sample for measurement of plasma lactate (Yellow Springs Instruments analyzer) or ascorbate, which was quantified by HPLC-based electrochemical assay (25) .
A bolus of ascorbate (10 or 200 mg/kg freshly dissolved in 0.1 mL of sterile saline), or a 0.1 mL bolus of sterile saline, was administered by a penile intravenous injection at 6 hrs post-FIP. In the majority of experiments, the bolus was injected immediately after the EDL muscle capillaries were initially viewed at 6 hrs post-FIP. Because this injection could not be done without altering the position of the mouse, repositioning and viewing of the same capillaries could be done only at 4 -10 mins after the injection. Regarding the choice of ascorbate doses, the higher dose prevented arteriolar hypocontractility in septic mice (11) and the lower dose approximated a dose given to human patients (29) . In separate mice, we also injected intravenously a bolus of putative NADPH oxidase inhibitor apocynin (10 mg/kg in 0.1 mL of saline) at 6 hrs post-FIP. Alternatively, the NOS cofactor (6R)-5,6,7,8-tetrahydro-L-biopterin (BH 4 , 0.1 mol/L), the NO donor S-nitroso-N-acetylpenicillamine (SNAP, 5 mol/L), decomposed SNAP (5 mol/L), or physiologic saline vehicle was applied locally to the muscle surface at 6 hrs post-FIP, by temporarily lifting the coverslip and superfusing the surface with a 0.1 mL bolus. The physiologic saline (in mmol/L, 132 NaCl, 4.7 KCl, 2.2 CaCl 2 , 1.2 MgSO 4 , and 20 NaHCO 3 ) was equilibrated with 5% CO 2 /95% N 2 to maintain pH 7.4 and warmed to 33-34°C. Decomposed SNAP was prepared by incubating SNAP in physiologic saline overnight at 37°C (30) .
To measure blood pressure, separate mice were anesthetized with ketamine/xylazine and the right internal carotid artery was cannulated with PE-10 tubing. As detailed by us (26), the cannula was tunneled subcutaneously to an incision in the back of the neck and attached to a swivel device, permitting access to water and food after recovery from anesthesia. The cannula was infused continuously with sterile saline (10 mL/h/kg) containing buprenorphine (33.3 g/h/kg). Mean arterial pressure was measured in awake mice at 0 hr and during the 6 -7 hrs post-FIP period.
NOS Activity Assay. EDL muscles were homogenized in five volumes (weight/volume) of homogenizing buffer (Tris-Cl 20 mmol/L, ethyleneglycoltetraacetic acid 1 mmol/L, ethylenediaminetetraacetic acid 1 mmol/L, dithiothreitol 1 mmol/L, phenylmethylsulfonyl fluoride 1 mmol/L, leupeptin 20 g/mL, and triton X-100 1%) and centrifuged (10,000 rpm for 20 mins at 4°C). The centrifugation was repeated on the supernatant. The NOS enzyme activity in muscle homogenates was measured as described previously (31) . The assay yielded measurements of the calcium-dependent constitutive NOS activity (i.e., eNOS ϩ nNOS) and the calcium-independent iNOS activity in the presence of excess cofactors. Total protein in lysates was measured using the BioRad DC protein assay.
Statistical Analysis. Data are presented as mean Ϯ SE; n indicates the number of mice. One EDL muscle per mouse was used. Data were analyzed by one-or two-way analysis of variance followed by post hoc Student's t-test with Bonferroni correction for multiple comparisons, unless otherwise stated. The level of significance was p Ͻ 0.05.
RESULTS

Model of Sepsis.
The FIP model of sepsis has been characterized according to several parameters (e.g., plasma cytokines, survival) (28) . Consistent with this previous report, we observed in WT mice (n ϭ 31) that survival was 100% at 6 hrs post-FIP, but only 97%, 84%, and 19% at 12, 18, and 24 hrs post-FIP, respectively. Plasma lactate increased from 0.7 Ϯ 0.3 mmol/L at 0 hr to 2.1 Ϯ 0.4 and to 3.1 Ϯ 1.3 mmol/L at 6 and 18 hrs post-FIP, respectively (n ϭ 5 or 6 mice per group, p Ͻ 0.05, Dunn's multiple comparison test). At 6 hrs after intraperitoneal saline injection in control mice, CD PER and CD STAT were 40.9 Ϯ 0.9 and 3.5 Ϯ 0.5 cap/mm (n ϭ 4), respectively. Because these CD PER and CD STAT values did not differ from those of naive mice (i.e., not exposed to any intervention), the values for saline-injected and naive mice were pooled in the control group of Figure 1 . CD PER decreases and CD STAT increases were observed at both 6 and 18 hrs post-FIP ( Fig. 1 ). Mice at 17.5 hrs post-FIP were difficult to prepare for intravital microscopy, because they could be easily overdosed and unintentionally euthanized with ketamine plus xylazine. Because capillary blood flow impairment was already fully developed at 6 hrs post-FIP, we studied the roles of NOS and NADPH oxidase at this time point. STAT ), were measured in control mice, and in septic mice at 6 hrs and 18 hrs after feces injection into peritoneum (FIP; 3.75 g/kg suspended in 50 mL/kg saline). Sepsis-impaired capillaryblood flow at 6 hrs and 18 hrs post-FIP. *Significant difference from control (n ϭ 11, 32, and 5 mice in control, 6-hr and 18-hr post-FIP groups, respectively; p Ͻ 0.05).
Effects of NOS and gp91phox Knockouts on Impaired Capillary Blood Flow in
Sepsis. In control saline-injected nNOS
Ϫ/Ϫ , iNOS Ϫ/Ϫ , eNOS Ϫ/Ϫ ,
and gp91phox
Ϫ/Ϫ mice, the CD PER and CD STAT values (data not shown) were comparable with those of WT mice ( Fig. 1, control) . Regarding CD PER and CD STAT values at 6 hrs post-FIP, there was no difference between WT and any of the NOS knockouts (Fig. 2) . By contrast, genetic deletion of gp91phox resulted in a marked 50% reduction in the density of nonperfused capillaries and a 40% increase in the density of perfused capillaries (Fig. 2 ). Similar to this effect, the NADPH oxidase inhibitor apocynin improved capillary blood flow in septic WT mice (Fig. 2) . Figure 3 shows that the constitutive NOS activity (i.e., eNOS ϩ nNOS) was dominated by nNOS (i.e., genetic deletion of nNOS dramatically reduced constitutive NOS activity), while iNOS activity was negligible, in both control and septic skeletal muscles. Sepsis at 6 hrs post-FIP did not affect constitutive NOS activity (Fig. 3) Figure 4A shows that the restorative effect of ascorbate persisted when capillary flow was observed at 60 mins postinjection (i.e., 7 hrs post-FIP) and again at 18 hrs post-FIP. Hyperemia was not observed at either time point. Consistently, the mean arterial blood pressure remained unchanged during the 60 mins postinjection period (Fig. 4B) . Figure 5A shows that the ascorbate bolus at 6 hrs post-FIP did not significantly alter plasma ascorbate concentration measured at 7 hrs post-FIP. Importantly, the ascorbate bolus improved survival of mice at 24 hrs post-FIP from 19% to 50% (Fig. 5B) . This finding agrees with the reported increased survival to 65% when ascorbate bolus is given at the onset of sepsis (cecal ligation and puncture model, CLP) (24) .
The next experiment examined the effect of 200 mg/kg ascorbate bolus injected at 6 hrs post-FIP. Here, the CD PER pre-and 60-min postinjection values were 25.6 Ϯ 1.5 and 37 Ϯ 2.7 cap/mm, respectively, (n ϭ 6, p Ͻ 0.05) while the corresponding CD STAT values were 26.3 Ϯ 1.9 and 14.6 Ϯ 1.8 cap/mm (n ϭ 6, p Ͻ 0.05). Further, pre-and 60-min postinjection V RBC values were 152 Ϯ 7 and Nitric oxide synthase (NOS) enzyme activities in extensor digitorum longus muscle in control and septic wild type and neuronal NOS (nNOS) Ϫ/Ϫ mice, at 6 -7 hrs post-feces injection into peritoneum (FIP). In wild type mice, sepsis, or sepsis plus ascorbate injection at 6 hrs post-FIP, did not alter constitutive NOS (cNOS) activity (i.e., total of endothelial NOS ϩ nNOS), while inducible NOS (iNOS) activity was negligible in the extensor digitorum longus muscle of all mice. Genetic deletion of nNOS dramatically reduced cNOS activity in control and septic muscles, indicating the constitutive NOS activity in wild type (wt) muscle was dominated by nNOS. n ϭ 4 or 5 muscles from four or five mice per group. illaries in six mice, p Ͼ 0.05), indicating that even this larger dose of ascorbate did not result in hyperemia within the capillary bed. Because of the similarity of the restorative effects of both ascorbate doses, we focused on elucidation of the mechanism of the lower dose (i.e., clinically relevant dose).
The following experiment asked if the restorative effect of ascorbate depends on NOS. Although enzymatic assay showed that ascorbate did not alter septic constitutive NOS and iNOS activities in whole muscle homogenates (Fig. 3) , a possible localized effect of ascorbate on NOS activity in cells within the microvasculature (i.e., occupying a small fraction of the . Effect of ascorbate bolus intravenous injection (10 mg/kg freshly dissolved in 0.1 mL of saline) on capillary (cap) blood flow in extensor digitorum longus muscle and on the mean arterial blood pressure (MAP) in septic wild type mice. A, Ascorbate was injected at 6 hrs post-feces injection into peritoneum (FIP) and subsequently moving red blood cells (CD PER ) and stationary red blood cells (CD STAT ) values were measured 7 hrs and 18 hrs post-FIP. Ascorbate reversed impaired capillary blood flow seen at 7 hrs and 18 hrs post-FIP. *Significant difference from respective nonascorbate group (i.e., mice given intravenous 0.1 mL saline bolus, or no bolus, at 6 hrs post-FIP). n ϭ 32 and 9 mice in nonascorbate and ascorbate groups, respectively, at 7 hrs post-FIP, and 5 and 4 mice in nonascorbate and ascorbate groups at 18 hrs post-FIP; p Ͻ 0.05. B, MAP at 0 hrs (control) and 6 hrs post-FIP (septic) was measured in separate groups of 5 and 10 awake mice, respectively. At 6 hrs, the 10 mice were randomly assigned to two groups of 5, which were injected with a 0.1 mL bolus of either ascorbate (10 mg/kg) or saline vehicle. MAP in these two groups was measured at 6.5 hrs and 7 hrs post-FIP. Sepsis reduced MAP at 6 hrs post-FIP. Neither ascorbate nor saline vehicle altered MAP at 6.5 hrs or 7 hrs post-FIP, compared with 6 hrs post-FIP. *Significant difference from control (p Ͻ 0.05). A, Control and septic mice were injected intravenously with saline or ascorbate at 6 hrs, and blood samples were collected at 7 hrs post-FIP. Analysis by two-way analysis of variance revealed no significant effect of sepsis or ascorbate on plasma ascorbate concentration at 7 hrs (n ϭ 5 and 6 for saline-injected control and septic mice, and 5 and 7 for ascorbate injected control and septic mice, respectively). B, Septic mice were monitored every 6 hrs for 24 hrs. Based on Kaplan-Meier survival analysis, survival of mice given ascorbate at 6 hrs post-FIP (n ϭ 32) was significantly higher (p Ͻ 0.05) than that of mice given saline (n ϭ 31).
skeletal muscle volume) might be undetectable by the assay. It has been shown that 1) enhanced adhesion of leukocytes, platelets and RBCs to the endothelium occurs in experimental sepsis (32-34) (i.e., a possible mechanism for impairment of capillary blood flow), and 2) this enhanced adhesion can be attenuated by NO (35, 36) . Because ascorbate increases levels of eNOS-derived NO in endothelial cells and platelets (27, (37) (38) (39) , we reasoned that the restorative effect on capillary flow could be eNOS-dependent. Alternatively, NOS-independence would indicate a possible direct antioxidant effect of ascorbate against NADPH oxidasederived ROS. Figure 6 demonstrates that the restorative effect was eNOS-dependent, because the lower ascorbate dose reversed septic capillary blood flow impairment in nNOS Ϫ/Ϫ , iNOS Ϫ/Ϫ , but not in eNOS Ϫ/Ϫ mice. The fact that the larger ascorbate dose also failed to reverse this impairment in eNOS Ϫ/Ϫ mice (data not shown) indicates that ascorbate did not exert other eNOS-independent restorative effects. Thus, the protective effect of ascorbate may be mediated by redox signaling involving eNOS, rather than by direct scavenging of ROS.
Experiments with endothelial cell cultures have shown that tetrahydrobiopterin (BH 4 ) synthesis is increased by bacterial lipopolysaccharide (40) but BH 4 concentration is decreased by ROS (41). Our finding that NADPH oxidase-derived ROS mediate septic impairment of capillary blood flow (Fig. 2) suggested that BH 4 may be oxidized during sepsis and that the restorative effect of ascorbate may be achieved through the maintenance of BH 4 in the reduced state required for it to function as a cofactor of eNOS (42, 43) . We reasoned that if the eNOS-dependent reversal by ascorbate of the impairment is due to an increase in endogenous BH 4 concentration, then exogenous supplementation of this cofactor at 6 hrs post-FIP will also restore capillary blood flow in WT but not eNOS Ϫ/Ϫ mice. In agreement with the reported hemodynamic improvement elicited by BH 4 analogue in endotoxin-injected rats (44), we discovered that superfusion of the EDL muscle surface with BH 4 during the 6 -7 hrs post-FIP period indeed restored capillary flow in WT but not in eNOS Ϫ/Ϫ mice (Fig. 7) . Superfusion with the vehicle had no effect on capillary blood flow in WT mice (data not shown). Thus, the restorative effects of ascorbate and BH 4 required the presence of eNOS, indicating that this isoform was involved in the rescue of capillary blood flow in sepsis.
Finally, we tested if exogenous BH 4 stimulates eNOS activity to increase NO production, and thus reverses capillary blood flow impairment in sepsis (35, 36) . To mimic increased NO production, we locally applied the NO donor SNAP at 6 hrs post-FIP. Figure 8 shows that SNAP restored capillary blood flow while decomposed SNAP had no effect (CD PER and CD STAT were measured at 15 mins post-SNAP; i.e., time when the temporary vasodilatory effect of SNAP had already ended). Thus, despite the persistence of nNOS to produce NO in septic skeletal muscle (Fig. 3) , supplemental NO may be required to rescue the capillary blood flow impairment. Experimental sepsis has been associated with a temporal window in which soluble guanylate cyclase is not functional (45) . The ability of NO to restore capillary blood flow (Fig. 8) attests to the functionality of soluble guanylate cyclase in the present model of sepsis.
DISCUSSION
Impaired blood flow within the capillary bed is a hallmark of sepsis (3, 46, 47) . Ϫ/Ϫ mice. *Significant difference from respective nonascorbate group. n ϭ 13 and six mice for nNOS Ϫ/Ϫ nonascorbate and ascorbate groups, n ϭ 11 and five mice for iNOS Ϫ/Ϫ nonascorbate and ascorbate groups, and n ϭ 14 and eight mice for eNOS Ϫ/Ϫ nonascorbate and ascorbate groups, respectively; p Ͻ 0.05. CD PER or CD STAT in nonsuperfused and vehiclesuperfused mice did not differ and therefore were pooled into one control group (labeled as "Ϫ"). BH 4 altered capillary blood flow in wild type (wt) but not in eNOS Ϫ/Ϫ mice. *Significant difference from control (n ϭ 32 and 6 mice for wt control and BH 4 groups, and n ϭ 14 and five mice for eNOS Ϫ/Ϫ control and BH 4 groups, respectively; p Ͻ 0.05).
We studied this impairment in a model of severe sepsis (19% survival at 24 hrs) because, in patients with severe sepsis, capillary blood flow improves in survivors but fails to improve in nonsurvivors (3, 5) . We report here three novel findings: 1) knockout of any single NOS isoform did not alter septic capillary blood flow impairment; 2) knockout of the NADPH oxidase subunit gp91phox and inhibition of NADPH oxidase significantly reduced the impairment; and 3) intravenous bolus of the antioxidant ascorbate rapidly and lastingly (at least for 12 hrs) reversed the impairment through an eNOS-dependent mechanism.
To our knowledge, there are no reports of the effect of NOS or NADPH oxidase subunit knockout on capillary blood flow in septic tissue. The present lack of effect of NOS knockout on capillary blood flow seems to be at odds with our own reports that iNOS knockout prevents arteriolar hypocontractility (24) and that nNOS knockout prevents arteriolar hypovasodilatation in septic mouse skeletal muscle (10) . However, restored arteriolar function in sepsis through iNOS/nNOS knockout may not necessarily lead to improved capillary blood flow. For example, increased adhesion between the endothelium and leukocytes, platelets or RBCs in sepsis (32-34) could precipitate capillary blood flow cessation, independent of arteriolar function. This independence of arteriolar versus capillary function was recently underscored by the report that impairment of capillary blood flow persisted or even worsened during vasopressor infusion in pigs exposed to FIP (48) .
Consistent with other reports dealing with septic skeletal muscle (14, 16, 17) , we show that nNOS is the dominant isozyme in this tissue. However, nNOSderived NO evidently is not responsible for impairment of capillary blood flow. First, sepsis did not alter nNOS activity, yet it markedly elevated the number of nonperfused capillaries. Second, genetic deletion of nNOS dramatically reduced constitutive NOS activity but did not prevent impairment of flow. In this regard, any restoration of mitochondrial function and adenosine 5Јtriphosphate concentration potentially achieved by suppressed NO production in sepsis (49) would also be unlikely to affect this impairment.
Inhibition of NO production in skeletal muscle with the nonspecific NOS inhibitor NG-nitro-L-arginine methyl ester can stop RBC flow in the muscle capillaries (50) . In view of the above-discussed dominance of nNOS isozyme, why did we not observe increased stoppage of flow in capillaries in both control and septic nNOS Ϫ/Ϫ mice? It is possible that blood flow in capillaries was facilitated by locally produced NO, generated by eNOS or iNOS in cells within or near the capillary wall (35, 36) . NOS activity in the small volume of these cells would not be detected by the present enzymatic assay performed in whole muscle homogenates. Nevertheless, Figure 2 indicates that this possible source of local NO was unlikely to account for the capillary blood flow impairment since no effect of eNOS or iNOS knockout was seen.
The protective effects of gp91phox knockout and apocynin (Fig. 2) indicate that NADPH oxidase-derived ROS are chiefly responsible for the capillary blood flow impairment in sepsis. Sepsis activates NADPH oxidase in microvascular endothelial cells and thus increases superoxide production in these cells (19) . Ascorbate inhibits this activation and ROS production by preventing sepsisinduced p47phox protein up-regulation (19) . The present findings that septic capillary blood flow impairment is NADPH oxidase-dependent, and is reversible by ascorbate, are consistent with these reports.
What accounts for the reversal by ascorbate? The absence of increased RBC velocity in capillaries after ascorbate injection indicates that the restoration of blood flow is not achieved through a vasodilatory effect of ascorbate, but rather through reestablishing blood flow at the capillary/venular level. It has been shown that enhanced adhesion of leukocytes, platelets and RBCs to the endothelium occurs in sepsis (32) (33) (34) and that ROSstimulated adhesion of leukocytes and platelets to the endothelium impedes microcirculatory blood flow (32, (51) (52) (53) . Because eNOS is expressed in both endothelial cells and platelets (39) , it is likely that the eNOS-dependent reversal effect of ascorbate depends on one or both of these cell types. However, detailed examination of eNOS-dependent endothelial/platelet interaction in capillaries (54) was beyond the objectives of the present study.
The present findings that BH 4 reverses the impairment eNOS-dependently and that exogenous NO also restores blood flow, and our preliminary observation that ascorbate does not dislodge adhering leukocytes in septic venules, support the following mechanism. In the presence of sepsis-induced ROS increase (11, 19) , BH 4 becomes oxidized and thereby uncouples eNOS to synthesize superoxide rather than NO (55) . At this point, genetic deletion of eNOS does not prevent the impairment of capillary blood flow, as eNOS is already "dysfunctional." Ascorbate prevents BH 4 oxidation, increases BH 4 content in platelets and endothelial cells, elevates their eNOS-derived NO (27, 37, 42) , reduces platelet aggregability (38, 39) and thus restores capillary blood flow. In addition to the BH 4 effect, ascorbate also releases NO from adducts (e.g., by ascorbate's reduction of S-nitrosothiols [56] ) that are synthesized from eNOSderived NO and stored in vascular tissue.
Astonishingly, the restorative effect of a single 10 mg/kg ascorbate bolus lasted at least 12 hrs (Fig. 4A) , despite normalization of ascorbate plasma level 1 hr postinjection (Fig. 5A ). This restoration is consistent with the reported restorative effect lasting 18 -24 hrs following a 76 mg/kg ascorbate bolus injection into CLP rats (26) . Microvascular endothelial cells of skeletal muscle origin accumulate a high level of intracellular ascorbate (up to 16 mmol/L) that persists longer than does extracellular ascorbate (57) . Thus, the eNOS and NO adducts in microvascu- lar endothelial cells may be exposed for prolonged periods to millimolar concentrations of ascorbate that cause them to produce NO. Millimolar concentrations of ascorbate are also high enough to prevent the interaction of superoxide and NO (58) , which is another way ascorbate accumulated in microvascular endothelial cells may restore NO-dependent capillary blood flow during sepsis. The decreased arterial pressure in FIP mice was not rescued by ascorbate at 1 hr after injection of the vitamin (Fig. 4B) . Impaired vascular (24, 11) and myocardial function (59) in sepsis cause hypotension. In CLP mice, a 200 mg/kg ascorbate injection at 3 hrs post-CLP rescued the arteriolar vasoconstrictor response but not hypotension at 6 hrs post-CLP, indicating that the initial target of ascorbate protection was microvascular rather than myocardial function (24) . However, in CLP rats, 76 mg/kg ascorbate injection at 24 hrs post-CLP prevented hypotension at 48 hrs post-CLP (26) . Thus, ascorbate bolus may not restore blood pressure rapidly, but rather over the longer period of 24 hrs when myocardial function may recover.
In conclusion, we used WT, nNOS Ϫ/Ϫ , iNOS Ϫ/Ϫ , eNOS Ϫ/Ϫ , and gp91phox
Ϫ/Ϫ mice to address the mechanism of impaired capillary blood flow in a model of severe sepsis. The impairment required NADPH oxidase but not NOS. Further, the impairment was rapidly and persistently reversed by ascorbate through an eNOS-dependent mechanism. We suggest that ascorbate bolus administration may be beneficial as an adjunct therapy in septic patients who retain sufficient eNOS protein expression, and whose survival depends on restoring capillary blood flow.
